Articles Archives - Page 301 of 733

MondayMar 21, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Writing the Playbook on M&A

Flora Growth’s two late 2021 acquisitions added an estimated $35 million in revenue and $7 million in EBITDA Its acquisition of Vessel Brand Inc. is projected to bring $35-$45 million in revenue for the 2022 calendar year With these acquisitions, the company, an internationally focused cannabis brand builder with a global distribution platform, stamps its position as an undisputed market and M&A leader In 2021, Flora Growth (NASDAQ: FLGC) completed its Initial Public Offering (“IPO”) and closed the acquisition of Vessel Brand Inc., a direct-to-consumer (“DTC”) business. The company also formed a joint venture to see the KaLaya brand's distribution…

MondayMar 21, 2022 9:00 am

2022 Virtual Growth Conference to Feature Roundtables, Fireside Chats with 250+ Companies

Companies and investors are encouraged to attend the 2022 Virtual Growth Conference being held as a virtual gathering March 28-30, 2022. The Virtual Growth Conference, organized by Maxim Group LLC and hosted by M-Vest, will provide a unique opportunity for attendees to interact with institutional investors and executives from 250+ companies. This year’s gathering will feature leaders from a diverse collection of industry sectors, including biotech, clean energy, electric vehicles, financial services, fintech & REITs, gaming & entertainment, healthcare, healthcare IT, infrastructure, shipping and technology/media/telecom. To RSVP for your virtual seat, visit https://ibn.fm/2022VirtualGrowth The 2022 Virtual Growth Conference kicks off…

FridayMar 18, 2022 2:30 pm

SRAX Inc. (NASDAQ: SRAX) Giving Execs a New Way to Get Investor’s Attention

In an age where investors are inundated with information and companies struggle to engage investors, SRAX provides an innovative platform for both, complete with due diligence tools, a large investor community and events SRAX expects full-year 2022 revenue of $46-$48 million, up 46%-52% over unaudited 2021 revenue Keeping investors’ attention has historically been hard, but it’s even more difficult today. As we entered the digital age and the flood of information becomes readily available, like the emergence of social media, prevalence of Reg As, and multitude of websites peddling more pump than fact, means keeping investor’s attention is even harder.…

FridayMar 18, 2022 9:15 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Offers a Glimpse into its R&D Pipeline, Patent Strategies, and Clinical Trials at March Investor Conferences

Mydecine participated in this year’s Annual Roth Conference, the Oppenheimer & Co. Annual Healthcare Conference, and will be at the upcoming Maxim Group’s Virtual Growth Conference These conferences represent an opportunity for the company to share its R&D pipeline, patent strategies and ongoing clinical trials Mydecine’s management has optimism for the future, as it taps into the growing psychedelics therapeutics and smoking cessation markets Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) has been at the forefront of developing novel psychedelic and non-psychedelic molecules for medical use. Its research and development efforts have focused on compounds that can enable safer and…

FridayMar 18, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Imports First CBD Products from Colombia Operations to U.S., with National Distribution Boost from Recent JustCBD Acquisition

Flora Growth is a cannabis cultivator and distributor operating a 100-hectare (about 247-acre) harvesting site called Cosechemos in central Colombia’s favorable growing climate Flora Growth has completed its first import of CBD-containing food and beverage products into the United States under its Mambe brand, thanks to Colombian regulatory changes in recent months allowing cannabis product exports Flora has filed licenses for 23 cannabinoid-infused food and beverage products with Colombia’s INVIMA food and drug regulatory body Imported Flora products will take advantage of the company’s U.S. distribution network customer database, which nearly doubled with last month’s acquisition of established CPG brand…

FridayMar 18, 2022 9:00 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands Bloombox Club Subsidiary to Austria; Educates Masses on Living Plant-Based Lifestyles

The Bloombox Club subsidiary of PlantX now offers e-commerce platform services in Austria, the United States, the United Kingdom, and Germany for house plant home delivery services PlantX currently offers over 5,000 plant-based and vegan products to consumers online and around the world Educational material can be found online through the PlantX blog, YouTube Channel, and Recipe Guides PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), a one-stop-shop for plant-based items, through its wholly-owned subsidiary Bloomboxclub Limited, is announcing the launch of its Bloombox Club e-commerce platform expansion into Austria. The Bloombox Club broadens the scope of the PlantX subsidiary’s…

FridayMar 18, 2022 9:00 am

Nowigence Inc. (NOWG) Putting Power of Data Science into Hands of Consumers

Company’s cloud-based, artificial intelligence (“AI”) platform, Pluaris(TM), is designed to read, organize and present mass amounts of information Nowigence has identified core challenges in the pursuit of knowledge that Pluaris is designed to solve A subscription-based SaaS product, the Pluaris platform can be used across different functions and sectors and can be adapted to each user’s needs In a world where consuming tremendous amounts of text-based information is an essential part of life — both personally and professionally — Nowigence Inc. (NOWG) is working to make this task easy and enjoyable. The company’s cloud-based, artificial intelligence (“AI”) platform, Pluaris, is…

ThursdayMar 17, 2022 9:15 am

SPYR Inc.’s (SPYR) Applied Magix Subsidiary Welcomes Former Senior Creative Director of Worldwide Marcom at Apple Inc. to Its Advisory Board

Fred Tio, the former senior creative director of Worldwide Marcom at Apple Inc., recently joined the Applied Magix advisory board Fred’s experience and advice is expected to be instrumental in helping Applied Magix grow The Applied Magix advisory board was created earlier this month with the aim of bringing together experienced and knowledgeable board members who, through consultation, will help the business grow and succeed SPYR (OTCQB: SPYR), a technology company that, through its Applied Magix Inc. subsidiary, operates in the Internet of Things (“IoT”) Smart Home and Connected Car spaces, recently announced Fred Tio, the former senior creative director…

ThursdayMar 17, 2022 9:15 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Aiming to Reach Millions of Mental Health Patients with Effective, Affordable Ketamine Treatments

Mental health conditions affect millions of people globally, some of whom are resistant to existing treatments In the early 1990s, Yale researchers discovered that ketamine offered immediate relief to chronically depressed patients, and since then, the scientists have continually investigated the compound’s role in mental health treatment Delic’s subsidiary, Ketamine Wellness Centers, notes that ketamine is now extensively used for multiple treatment-resistant mental conditions, with patient outcomes showing its therapeutic effectiveness Delic hopes to reach millions of people suffering from various mental health conditions who have lost hope of finding effective, affordable treatments The World Health Organization (“WHO”) reports that…

ThursdayMar 17, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) on Leading Edge of Development of Psychedelics as Public Support Grows

More than 60% of American who suffer from mental health conditions want access to psychedelic options Growing number of cities, states looking at decriminalizing use of psychedelic medicine Cybin is working with world-class partners, internationally recognized scientists to create safe, effective therapeutics in the mental-health space The awareness of psychedelics and the potential for treating an array of mental health diseases is growing, as evidenced by a recent survey reporting that 65% of affected Americans want access to psychedelics for potential treatment (https://ibn.fm/jIV2K). Those are numbers that Cybin (NEO: CYBN) (NYSE American: CYBN), a leading ethical biopharmaceutical company, is paying close attention…

Site Search

Company Search

Category: Articles

Flora Growth Corp. (NASDAQ: FLGC) Writing the Playbook on M&A

2022 Virtual Growth Conference to Feature Roundtables, Fireside Chats with 250+ Companies

SRAX Inc. (NASDAQ: SRAX) Giving Execs a New Way to Get Investor’s Attention

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Offers a Glimpse into its R&D Pipeline, Patent Strategies, and Clinical Trials at March Investor Conferences

Flora Growth Corp. (NASDAQ: FLGC) Imports First CBD Products from Colombia Operations to U.S., with National Distribution Boost from Recent JustCBD Acquisition

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands Bloombox Club Subsidiary to Austria; Educates Masses on Living Plant-Based Lifestyles

Nowigence Inc. (NOWG) Putting Power of Data Science into Hands of Consumers

SPYR Inc.’s (SPYR) Applied Magix Subsidiary Welcomes Former Senior Creative Director of Worldwide Marcom at Apple Inc. to Its Advisory Board

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Aiming to Reach Millions of Mental Health Patients with Effective, Affordable Ketamine Treatments

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) on Leading Edge of Development of Psychedelics as Public Support Grows

Market Basics

Newsletter Publishers

Public Companies